Jemperli Granted Full Approval for dMMR Recurrent or Advanced Endometrial Cancer
The conversion to regular approval was based on data from an additional 141 patients with dMMR recurrent or advanced endometrial cancer who had progressed on or after a platinum-containing regimen.